SEVPX
Price
$40.79
Change
-$0.28 (-0.68%)
Updated
Sep 20 closing price
VMVAX
Price
$86.17
Change
-$0.37 (-0.43%)
Updated
Sep 20 closing price
Ad is loading...

SEVPX vs VMVAX

Header iconSEVPX vs VMVAX Comparison
Open Charts SEVPX vs VMVAXBanner chart's image
Guggenheim SMid Cap Value P
Price$40.79
Change-$0.28 (-0.68%)
VolumeN/A
CapitalizationN/A
Vanguard Mid-Cap Value Index Admiral
Price$86.17
Change-$0.37 (-0.43%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
SEVPX vs VMVAX Comparison Chart
Loading...
VS
SEVPX vs. VMVAX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SEVPX is a StrongBuy and VMVAX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VMVAX has more cash in the bank: 30.5B vs. SEVPX (374M). VMVAX pays higher dividends than SEVPX: VMVAX (2.14) vs SEVPX (0.13). SEVPX was incepted earlier than VMVAX: SEVPX (9 years) vs VMVAX (13 years). SEVPX is a more actively managed with annual turnover of: 28.00 vs. VMVAX (22.00). SEVPX has a lower initial minimum investment than VMVAX: SEVPX (0) vs VMVAX (3000). VMVAX annual gain was more profitable for investors over the last year : 25.35 vs. SEVPX (17.96). VMVAX return over 5 years is better than : 48.82 vs. SEVPX (36.33).
SEVPXVMVAXSEVPX / VMVAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years13 years-
Gain YTD9.56214.94664%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets374M30.5B1%
Annual Yield % from dividends0.132.146%
Returns for 1 year17.9625.3571%
Returns for 3 years12.0420.7158%
Returns for 5 years36.3348.8274%
Returns for 10 yearsN/A100.88-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AUUD0.790.01
+0.67%
Auddia
CTLT60.00-0.11
-0.18%
CATALENT
JAMF18.49-0.09
-0.48%
Jamf Holding Corp
ARCT20.61-0.41
-1.95%
Arcturus Therapeutics Holdings
ANVS8.47-0.17
-1.97%
Annovis Bio